Relationship Between Menopausal Hormone Therapy and Oral Cancer: A Cohort Study Based on the Health Insurance Database in South Korea

Overview

Journal J Clin Med

Specialty General Medicine

Date 2022 Oct 14

PMID 36233715

Authors

Jin-Sung Yuk

Bo Young Kim

Affiliations

Soon will be listed here.

Abstract

The association between the development of oral cavity cancer and sex hormones is unclear and inconsistent. This study aimed to evaluate the relationship between menopausal hormone therapy (MHT) and oral cavity cancer in menopausal women in Korea. In this retrospective cohort study, data were provided by the Korean National Health Insurance Service regarding a screening examination conducted from 1 January 2002 to 31 December 2019. Postmenopausal patients aged ≥40 years were considered, including 333,072 women in the MHT group and 847,558 women in the non-MHT group. Participants were divided into MHT types (tibolone, combined estrogen plus progestin by manufacturer, estrogen, combined estrogen plus progestin by physician, and topical estrogen), and the risk factors for oral cavity cancer development were analyzed. There was no significant association between smoking, alcohol consumption, age at menarche, and age at menopause with oral cavity cancer in postmenopausal women. However, the oral estrogen (hazard ratio [HR]: 1.633; 95% confidence interval [CI]: 1.35-1.976) and tibolone groups (HR: 1.633; 95% CI: 1.35-1.976) were associated with an elevated risk of oral cavity cancer. The results of this study suggest that MHT increases the risk of oral cavity cancer in postmenopausal women.

Citing Articles

The Role of Estrogen and Estrogen Receptors in Head and Neck Tumors.

Kranjcevic J, conkas J, Ozretic P Cancers (Basel). 2024; 16(8).

PMID: 38672656 PMC: 11049451. DOI: 10.3390/cancers16081575.

Personalized Medicine in Oral Oncology: Imaging Methods and Biological Markers to Support Diagnosis of Oral Squamous Cell Carcinoma (OSCC): A Narrative Literature Review.

Menditti D, Santagata M, Imola G, Stagliano S, Vitagliano R, Emiliano Boschetti C J Pers Med. 2023; 13(9).

PMID: 37763165 PMC: 10532745. DOI: 10.3390/jpm13091397.

Oral Cavity Squamous Cell Carcinoma Risk Factors: State of the Art.

Nokovitch L, Maquet C, Crampon F, Taihi I, Roussel L, Obongo R J Clin Med. 2023; 12(9).

PMID: 37176704 PMC: 10179259. DOI: 10.3390/jcm12093264.

References

Krolls S, Hoffman S . Squamous cell carcinoma of the oral soft tissues: a statistical analysis of 14,253 cases by age, sex, and race of patients. J Am Dent Assoc. 1976; 92(3):571-4. DOI: 10.14219/jada.archive.1976.0556. View

Bosetti C, Negri E, Franceschi S, Conti E, Levi F, Tomei F . Risk factors for oral and pharyngeal cancer in women: a study from Italy and Switzerland. Br J Cancer. 2000; 82(1):204-7. PMC: 2363177. DOI: 10.1054/bjoc.1999.0900. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Freedman N, Lacey Jr J, Hollenbeck A, Leitzmann M, Schatzkin A, Abnet C . The association of menstrual and reproductive factors with upper gastrointestinal tract cancers in the NIH-AARP cohort. Cancer. 2010; 116(6):1572-81. PMC: 2836418. DOI: 10.1002/cncr.24880. View

Wiseman S, Swede H, Stoler D, Anderson G, Rigual N, Hicks Jr W . Squamous cell carcinoma of the head and neck in nonsmokers and nondrinkers: an analysis of clinicopathologic characteristics and treatment outcomes. Ann Surg Oncol. 2003; 10(5):551-7. DOI: 10.1245/aso.2003.09.010. View

DeAngelis A, Breik O, Koo K, Iseli T, Nastri A, Fua T . Non-smoking, non-drinking elderly females, a 5 year follow-up of a clinically distinct cohort of oral squamous cell carcinoma patients. Oral Oncol. 2018; 86:113-120. DOI: 10.1016/j.oraloncology.2018.09.004. View

Koo K, Barrowman R, McCullough M, Iseli T, Wiesenfeld D . Non-smoking non-drinking elderly females: a clinically distinct subgroup of oral squamous cell carcinoma patients. Int J Oral Maxillofac Surg. 2013; 42(8):929-33. DOI: 10.1016/j.ijom.2013.04.010. View

Egloff A, Rothstein M, Seethala R, Siegfried J, Grandis J, Stabile L . Cross-talk between estrogen receptor and epidermal growth factor receptor in head and neck squamous cell carcinoma. Clin Cancer Res. 2009; 15(21):6529-40. PMC: 2783886. DOI: 10.1158/1078-0432.CCR-09-0862. View

Cummings S, Ettinger B, Delmas P, Kenemans P, Stathopoulos V, Verweij P . The effects of tibolone in older postmenopausal women. N Engl J Med. 2008; 359(7):697-708. PMC: 3684062. DOI: 10.1056/NEJMoa0800743. View

10.

Fernandez E, Gallus S, Bosetti C, Franceschi S, Negri E, La Vecchia C . Hormone replacement therapy and cancer risk: a systematic analysis from a network of case-control studies. Int J Cancer. 2003; 105(3):408-12. DOI: 10.1002/ijc.11083. View

11.

Lukits J, Remenar E, Raso E, Ladanyi A, Kasler M, Timar J . Molecular identification, expression and prognostic role of estrogen- and progesterone receptors in head and neck cancer. Int J Oncol. 2006; 30(1):155-60. DOI: 10.3892/ijo.30.1.155. View

12.

Suba Z . Gender-related hormonal risk factors for oral cancer. Pathol Oncol Res. 2007; 13(3):195-202. DOI: 10.1007/BF02893499. View

13.

Farshadpour F, Hordijk G, Koole R, Slootweg P . Non-smoking and non-drinking patients with head and neck squamous cell carcinoma: a distinct population. Oral Dis. 2007; 13(2):239-43. DOI: 10.1111/j.1601-0825.2006.01274.x. View

14.

Chang Y, Hsu Y, Wu T, Huang C, Liou L, Chiu Y . Regulation of estrogen receptor α function in oral squamous cell carcinoma cells by FAK signaling. Endocr Relat Cancer. 2014; 21(4):555-65. DOI: 10.1530/ERC-14-0102. View

15.

Corrao G, Zambon A, Conti V, Nicotra F, La Vecchia C, Fornari C . Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation. Ann Oncol. 2007; 19(1):150-5. DOI: 10.1093/annonc/mdm404. View

16.

Langevin S, Grandis J, Taioli E . Female hormonal and reproductive factors and head and neck squamous cell carcinoma risk. Cancer Lett. 2011; 310(2):216-21. PMC: 3169650. DOI: 10.1016/j.canlet.2011.07.007. View

17.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

18.

. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause. 2017; 24(7):728-753. DOI: 10.1097/GME.0000000000000921. View

19.

Gallus S, Bosetti C, Franceschi S, Levi F, Negri E, La Vecchia C . Laryngeal cancer in women: tobacco, alcohol, nutritional, and hormonal factors. Cancer Epidemiol Biomarkers Prev. 2003; 12(6):514-7. View

20.

Kumar M, Nanavati R, Modi T, Dobariya C . Oral cancer: Etiology and risk factors: A review. J Cancer Res Ther. 2016; 12(2):458-63. DOI: 10.4103/0973-1482.186696. View